A Study to Evaluate the Effectiveness and Safety of RXI 109 on the Outcome of Scar Revision Surgery in Healthy Adults

NCT02030275 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

25

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypertrophic Scar

Interventions

DRUG: RXI-109
DRUG: Placebo

Sponsor

RXi Pharmaceuticals, Corp.